Literature DB >> 25902328

Synthesis of new carolacton derivatives and their activity against biofilms of oral bacteria.

N Stumpp1, P Premnath, T Schmidt, J Ammermann, G Dräger, M Reck, R Jansen, M Stiesch, I Wagner-Döbler, A Kirschning.   

Abstract

Carolacton, a secondary metabolite isolated from the extracts of Sorangium cellulosum, causes membrane damage and cell death in biofilms of the caries- and endocarditis-associated bacterium Streptococcus mutans. Here, we report the total synthesis of several derivatives of carolacton. All new structural modifications introduced abolished its biological activity, including subtle ones, such as inversion of configuration at C9. However, a bicyclic bislactone derivative as well as the methyl ester of carolacton resulted in compounds with prodrug properties. Their inhibitory activity on S. mutans was proven to be based on enzymatic hydrolysis by S. mutans which provided native carolacton resulting in biofilm damage in vivo. Moreover, we demonstrate that carolacton acts also on S. gordonii, S. oralis and the periodontitis pathogen Aggregatibacter actinomycetemcomitans, causing elongated cells and growth inhibition.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25902328     DOI: 10.1039/c5ob00460h

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  10 in total

1.  Natural products as inspiration for the development of bacterial antibiofilm agents.

Authors:  Roberta J Melander; Akash K Basak; Christian Melander
Journal:  Nat Prod Rep       Date:  2020-07-01       Impact factor: 13.423

Review 2.  Targeting S. mutans biofilms: a perspective on preventing dental caries.

Authors:  Amber M Scharnow; Amy E Solinski; William M Wuest
Journal:  Medchemcomm       Date:  2019-03-19       Impact factor: 3.597

3.  Diverted Total Synthesis of Carolacton-Inspired Analogs Yields Three Distinct Phenotypes in Streptococcus mutans Biofilms.

Authors:  Amy E Solinski; Alexander B Koval; Richard S Brzozowski; Kelly R Morrison; Americo J Fraboni; Carrie E Carson; Anisa R Eshraghi; Guangfeng Zhou; Robert G Quivey; Vincent A Voelz; Bettina A Buttaro; William M Wuest
Journal:  J Am Chem Soc       Date:  2017-05-17       Impact factor: 15.419

Review 4.  Instructive Advances in Chemical Microbiology Inspired by Nature's Diverse Inventory of Molecules.

Authors:  Ke Liu; Robert W Huigens
Journal:  ACS Infect Dis       Date:  2020-01-06       Impact factor: 5.084

Review 5.  Natural Products as Platforms To Overcome Antibiotic Resistance.

Authors:  Sean E Rossiter; Madison H Fletcher; William M Wuest
Journal:  Chem Rev       Date:  2017-09-27       Impact factor: 60.622

6.  Honokiol-Inspired Analogs as Inhibitors of Oral Bacteria.

Authors:  Amy E Solinski; Cristian Ochoa; Young Eun Lee; Thomas Paniak; Marisa C Kozlowski; William M Wuest
Journal:  ACS Infect Dis       Date:  2017-12-13       Impact factor: 5.084

7.  Synthetic Simplification of Carolacton Enables Chemical Genetic Studies in Streptococcus mutans.

Authors:  Amy E Solinski; Amber M Scharnow; Americo J Fraboni; William M Wuest
Journal:  ACS Infect Dis       Date:  2019-06-25       Impact factor: 5.084

8.  Carolacton Treatment Causes Delocalization of the Cell Division Proteins PknB and DivIVa in Streptococcus mutans in vivo.

Authors:  Michael Reck; Irene Wagner-Döbler
Journal:  Front Microbiol       Date:  2016-05-11       Impact factor: 5.640

9.  The biofilm inhibitor Carolacton inhibits planktonic growth of virulent pneumococci via a conserved target.

Authors:  Jannik Donner; Michael Reck; Simone Bergmann; Andreas Kirschning; Rolf Müller; Irene Wagner-Döbler
Journal:  Sci Rep       Date:  2016-07-11       Impact factor: 4.379

10.  The Biofilm Inhibitor Carolacton Enters Gram-Negative Cells: Studies Using a TolC-Deficient Strain of Escherichia coli.

Authors:  Jannik Donner; Michael Reck; Boyke Bunk; Michael Jarek; Constantin Benjamin App; Jan P Meier-Kolthoff; Jörg Overmann; Rolf Müller; Andreas Kirschning; Irene Wagner-Döbler
Journal:  mSphere       Date:  2017-09-27       Impact factor: 4.389

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.